Numerous clinical trials have been recently completed and will continue to define the value of proton therapy - June 4 at ASCO IMPT IMRT for OPC head and neck cancer MD Anderson Cancer Center National Association for Proton Therapy ASTRO PTCOG

Congratulations to Menna Teferra, MS for her presentation on PRO collections for the Phase III HN randomized trial for IMPT vs IMRT in oropharyngeal cancer MD Anderson Cancer Center National Association for Proton Therapy

Generous donation by broadcaster and patient Buck Martinez MD Anderson Cancer Center This bench will bring great comfort to families at Proton Therapy Center 2. Buck’s proton therapy experience: bit.ly/43Kc51E #ProtonTherapy Toronto Blue Jays #HNCSM #EndCancer

Comprehensive insights on the underlying potential and advantage of proton therapy over IMRT as highlighted in a wide real world data analysis . . . Level 1 data is coming ASCO bit.ly/49zodDZ MD Anderson Cancer Center #ProtonTherapy #EndCancer National Association for Proton Therapy

takesteps.crohnscolitisfoundation.org/index.cfm?fuse… Please join Maddie and Maddie’s Gutsy Gang to Take Steps toward cures for Crohn’s Crohn's & Colitis Foundation

Exciting work presented by Dr. Kathryn Marqueen, mentored by Steven J. Frank, MD, on how patients with oropharynx cancer treated with IMPT had ⬇️ gastrostomy-tube dependence vs. IMRT. MD Anderson Cancer Center #ARS2024

Hot off the press - ASCO H+N abstracts - quick look at amazing Ph3 RCT of proton vs photon for oropharynx cancer IMPT with non-inf PFS (HR 0.87) w/significantly less PEG and less wt loss Can't wait to see the pres for details but is this new SoC? meetings.asco.org/abstracts-pres…

David Sher James Bates ASCO I agree. Plus, we don’t know if the baseline nutrition and dysphasia rates were balanced between arms (this didn’t seem to be a requirement). Steven J. Frank, MD

Congratulations to all participating institutions for driving Phase III Level I evidence for proton therapy in head and neck malignancies to be presented ASCO on June 4th. meetings.asco.org/abstracts-pres… MD Anderson Cancer Center National Association for Proton Therapy ASTRO

A pathway to MRI-Assisted Radiosurgery (MARS) HDR brachytherapy Bit.ly/3wPcPqk “we have the technology” American Brachy Peter Rossi MIM Software

#radonc ASCO Steven J. Frank, MD oncodaily.com/73277.html Phase III Level I evidence for proton therapy in head and neck malignancies

Congratulations to MD Anderson Cancer Center and all the participating institutions for developing Level 1 evidence for proton therapy for oropharyngeal tumors Albert Koong, MD PhD PTCOG ASTRO PTCOG-NA National Association for Proton Therapy

The results of this multi-center Phase III randomized trial by Steven J. Frank, MD - MD Anderson Cancer Center oncodaily.com/77903.html #ASCO24 #Cancer #OncoDaily #Oncology #ProtonTherapy

Congratulations to Steven J. Frank, MD for an outstanding presentation of the first phase III randomized study to compare IMRT vs IMPT in H/N cancer, showing improvement of toxicity and trend of OS with proton TX MD Anderson Cancer Center The Particle Therapy Co-Operative Group (PTCOG)

Instead of removing the eye, proton therapy provides an orbit sparing approach for cure, clear vision, and good cosmesis (3Cs) for periorbital tumors MD Anderson Cancer Center

MRI-Assisted Radiosurgery - MARS LDR Brachytherapy - Optimizing quality assurance and increasing dose to dominant intraprostatic lesions while avoiding the external urethral sphincter (EUS) MD Anderson Cancer Center Albert Koong, MD PhD

Wonderful to spend time w/ @andreakng1 Michael Yunes ⁦Brian J. Davis, MD, PhD⁩ catheryn yashar Steven J. Frank, MD Ken Rosenzweig during the American Board of Radiology board meeting in Santa Fe! We greatly look forward to seeing everyone at #ASTRO24! ⁦ASTRO⁩

Twins separated at birth? ⁦Steven J. Frank, MD⁩ #radonc #endcancer ⁦MD Anderson Cancer Center⁩

Joe Y Chang Shared PTCOG 2025 Phase III Data on IMPT vs. IMRT in Head and Neck Cancer Joe Y Chang The Particle Therapy Co-Operative Group (PTCOG) Steven J. Frank, MD oncodaily.com/insight/ptcog-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews CancerWorld

Raffaele Di Giacomo, PhD The Particle Therapy Co-Operative Group (PTCOG) Steven J. Frank, MD Feeding tube rate is significantly reduced, pts returns to work sooner with IMPT. I hope that it will change the NCCN guidelines.